NO20084954L - Biomarkorer for hepatitt-C-virusinfeksjon - Google Patents

Biomarkorer for hepatitt-C-virusinfeksjon

Info

Publication number
NO20084954L
NO20084954L NO20084954A NO20084954A NO20084954L NO 20084954 L NO20084954 L NO 20084954L NO 20084954 A NO20084954 A NO 20084954A NO 20084954 A NO20084954 A NO 20084954A NO 20084954 L NO20084954 L NO 20084954L
Authority
NO
Norway
Prior art keywords
hepatitis
virus infection
biomarkers
genes associated
virus
Prior art date
Application number
NO20084954A
Other languages
English (en)
Inventor
Martyn C Botfield
Ravi K Ramachandran
Matthew W Harding
Paul R Caron
Brian J Hare
Raj Bandaru
Kevin M Kelliher
Catharine N Cornell
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of NO20084954L publication Critical patent/NO20084954L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00—Reactions characterised by their quantitative nature
    • C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/114—Reactions characterised by their quantitative nature the purpose being quantitative analysis involving a quantitation step

Abstract

En signatursamling av gener som er assosiert med hepatitt C virusinfeksjon blir beskrevet.
NO20084954A 2006-04-26 2008-11-25 Biomarkorer for hepatitt-C-virusinfeksjon NO20084954L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79552006P 2006-04-26 2006-04-26
PCT/US2007/067421 WO2007127801A2 (en) 2006-04-26 2007-04-25 Hepatitis c virus infection biomarkers

Publications (1)

Publication Number Publication Date
NO20084954L true NO20084954L (no) 2009-01-22

Family

ID=38656353

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084954A NO20084954L (no) 2006-04-26 2008-11-25 Biomarkorer for hepatitt-C-virusinfeksjon

Country Status (13)

Country Link
US (1) US20100028874A1 (no)
EP (1) EP2016195A4 (no)
JP (1) JP2009535036A (no)
KR (1) KR20090023360A (no)
CN (1) CN101479389A (no)
AU (1) AU2007244824A1 (no)
CA (1) CA2650616A1 (no)
IL (1) IL194920A0 (no)
MX (1) MX2008013796A (no)
NO (1) NO20084954L (no)
NZ (1) NZ573052A (no)
RU (1) RU2008146518A (no)
WO (1) WO2007127801A2 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8399615B2 (en) 2005-08-19 2013-03-19 Vertex Pharmaceuticals Incorporated Processes and intermediates
JP2009178057A (ja) * 2008-01-29 2009-08-13 Miyazakiken Sangyo Shien Zaidan インターフェロンとリバビリンとの併用治療効果の検出方法および検出キット
WO2010036799A1 (en) * 2008-09-24 2010-04-01 Vertex Pharmaceuticals Incorporated Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis "
CA2796666C (en) * 2010-04-21 2020-04-14 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
CN102178927A (zh) * 2011-03-01 2011-09-14 中国人民解放军军事医学科学院放射与辐射医学研究所 干扰素诱导跨膜蛋白3在制备抗乙型肝炎病毒感染药物中的用途
CN102323426A (zh) * 2011-08-08 2012-01-18 中国人民解放军军事医学科学院放射与辐射医学研究所 用于诊断或筛查丙型肝炎病毒感染的试剂
US9726668B2 (en) 2012-02-09 2017-08-08 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
WO2015157639A1 (en) * 2014-04-11 2015-10-15 Globeimmune, Inc. Yeast-based immunotherapy and type i interferon sensitivity
EP3180621B1 (en) 2014-08-14 2020-04-01 Memed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
JP6968696B2 (ja) * 2014-08-22 2021-11-17 インファン・リウ 異常なレベル及び／又は活性のｉｆｐ３５ファミリーのタンパク質に関連する疾患又は障害を治療及び／又は予防するための方法及び組成物
WO2016059636A1 (en) 2014-10-14 2016-04-21 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
WO2017149548A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
KR102515555B1 (ko) 2016-06-07 2023-03-28 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 세균성 감염 및 바이러스성 감염의 진단 방법
CN109804245B (zh) 2016-07-10 2022-10-25 米密德诊断学有限公司 感染的早期诊断
EP4141448A1 (en) 2016-07-10 2023-03-01 MeMed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
EP3519834A4 (en) 2016-09-29 2020-06-17 MeMed Diagnostics Ltd. RISK ASSESSMENT AND DISEASE CLASSIFICATION METHODS
US11385241B2 (en) 2016-09-29 2022-07-12 Memed Diagnostics Ltd. Methods of prognosis and treatment
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
CN108379584B (zh) * 2018-04-12 2020-08-11 上海交复生物医药科技有限公司 RSAD2通过wnt通路影响肿瘤细胞替莫唑胺耐药性
CN110448548B (zh) * 2018-05-08 2023-05-05 四川大学华西医院 Ifitm2抑制剂在制备治疗乙型肝炎的药物中的用途
KR102289533B1 (ko) * 2019-08-19 2021-08-17 주식회사 테라젠바이오 특정 약물의 타겟 유전자와 관련된 시그니처를 기초로 타겟 유전자와 관련된 유전자들을 판단하는 전자 장치, 방법 및 상기 방법을 실행하기 위한 컴퓨터 프로그램
CN111333710B (zh) * 2020-03-04 2021-12-03 暨南大学 C20orf24蛋白缺失突变体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0407587A (pt) * 2003-02-18 2006-02-14 Pfizer inibidores do vìrus da hepatite c, composições e tratamentos que os utilizam
US20050282179A1 (en) * 2003-12-05 2005-12-22 Applera Corporation Biomarkers for interferon-alpha response in hepatitis C virus infected patients
EP1831403A4 (en) * 2004-12-30 2010-04-28 Univ Louisville Res Found GENETIC MARKERS OF SCHIZOPHRENIA

Also Published As

Publication number Publication date
AU2007244824A1 (en) 2007-11-08
WO2007127801A2 (en) 2007-11-08
CN101479389A (zh) 2009-07-08
EP2016195A2 (en) 2009-01-21
RU2008146518A (ru) 2010-06-10
JP2009535036A (ja) 2009-10-01
CA2650616A1 (en) 2007-11-08
US20100028874A1 (en) 2010-02-04
WO2007127801A3 (en) 2008-09-12
KR20090023360A (ko) 2009-03-04
EP2016195A4 (en) 2010-03-10
MX2008013796A (es) 2009-03-31
NZ573052A (en) 2012-03-30
IL194920A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
NO20084954L (no) Biomarkorer for hepatitt-C-virusinfeksjon
EA201100850A1 (ru) Фосфорамидаты нуклеозидов
EA201100851A1 (ru) Аналоги нуклеозидов
EA201171378A1 (ru) Соединения галогеналкилгетероарилбензамида
ECSP10010260A (es) Inhibidores de la polimerasa vírica
CY2015004I2 (el) Αναστολεις του ιου της ηπατιτιδας c
EA201270423A1 (ru) Ингибиторы протеазы hcv
GEP20146134B (en) Inhibitors of hepatitis c virus replication
BRPI0917460A2 (pt) parede interna de uma nacela de turbomáquina, e turbomáquina
AP2010005416A0 (en) Novel macrocyclic inhibitors of hepatitis c virus replication.
DK2242752T3 (da) Imidazolyl-biphenylimidazoler som hepatitis C-virus-inhibitorer
EA200901101A1 (ru) Макроциклические соединения в качестве ингибиторов протеазы ns3 вгс
DK2245027T3 (da) Hepatitis C-virusinhibitorer
CL2012002489A1 (es) Compuestos derivados de sililo nafto-imidazol; composición farmacéutica; y su uso para prevenir o tratar una infección por el virus de la hepatitis c.
DK1912999T3 (da) Makrocykliske inhibitorer af hepatitis-c-virus
DK1912997T3 (da) Makrocycliske inhibitorer af hepatitis C virus
DK1919898T3 (da) Makrocykliske inhibitorer af hepatitis-C-virus
DK1912996T3 (da) Makrocykliske inhibitorer af hepatitis C-virus
DK1912981T3 (da) Makrocykliske inhibitorer af Hepatitis C-virus
DK1912995T3 (da) Makrocykliske inhibitorer af hepatitis C virus
DK1919899T3 (da) Makrocykliske inhibitorer af hepatitis C virus
MX2010001358A (es) Compuestos de tiazolida sustituidos con alquilsulfonilo.
DK1913014T3 (da) Makrocykliske inhibitorer af hepatitis-c-virus
BRPI0907733A2 (pt) Inibidores do vírus da hepatite c
DE602007000064D1 (de) Ringförmige Brennkammer eines Turbotriebwerks

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application